Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United Kingdom primary care

American Journal of Cardiology

Volumn 112, Issue 8, 2013, Pages 1075-1082

  Martín Merino, Elisa ^a   Johansson, Saga ^b   Nagy, Péter ^b   García Rodríguez, Luis A ^a  

^a Spanish Centre for Pharmacoepidemiologic Research ^*  (Spain)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DIGOXIN; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; WARFARIN;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG WITHDRAWAL; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OSTEOARTHRITIS; PATIENT; PATIENT REFERRAL; PEPTIC ULCER; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK; RISK FACTOR; SECONDARY PREVENTION; SMOKING; THERAPY; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM; UNSTABLE ANGINA PECTORIS;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PRIMARY HEALTH CARE; PROGNOSIS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION; TIME FACTORS;

EID: 84884905759     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.05.051     Document Type: Article

References (21)

1. C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, R. Peto, J. Buring, C. Hennekens, P. Kearney, T. Meade, C. Patrono, M.C. Roncaglioni, and A. Zanchetti Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
2. L.A. García Rodriguez, L. Cea-Soriano, E. Martin-Merino, and S. Johansson Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care BMJ 343 2011 d4094
3. L.A. García Rodríguez, L. Cea Soriano, C. Hill, and S. Johansson Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study Neurology 76 2011 740 746
4. E. Ferrari, M. Benhamou, P. Cerboni, and B. Marcel Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis J Am Coll Cardiol 45 2005 456 459
5. G.G. Biondi-Zoccai, M. Lotrionte, P. Agostoni, A. Abbate, M. Fusaro, F. Burzotta, L. Testa, I. Sheiban, and G. Sangiorgi A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease Eur Heart J 27 2006 2667 2674
6. A.B. Maulaz, D.C. Bezerra, P. Michel, and J. Bogousslavsky Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke Arch Neurol 62 2005 1217 1220
7. E. Martín-Merino, S. Johansson, H. Bueno, and L. García Rodríguez Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease Prag Obs Res 3 2012 1 9
8. S. Pratt, V.J. Thompson, E.P. Elkin, J. Naesdal, and E. Sorstadius The impact of upper gastrointestinal symptoms on nonadherence to, and discontinuation of, low-dose acetylsalicylic acid in patients with cardiovascular risk Am J Cardiovasc Drugs 10 2010 281 288
9. J. Herlitz, P.P. Toth, and J. Naesdal Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation Am J Cardiovasc Drugs 10 2010 125 141
10. C. Moberg, J. Naesdal, L.-E. Svedberg, D. Duchateau, and N. Harte Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic acid: a quantitative study in patients with cardiovascular risk Patient 4 2011 103 113
11. N.S. Abraham, M.A. Hlatky, E.M. Antman, D.L. Bhatt, D.J. Bjorkman, C.B. Clark, C.D. Furberg, D.A. Johnson, C.J. Kahi, L. Laine, K.W. Mahaffey, E.M. Quigley, J. Scheiman, L.S. Sperling, and G.F. Tomaselli ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use Circulation 122 2010 2619 2633
12. D.L. Bhatt, J. Scheiman, N.S. Abraham, E.M. Antman, F.K. Chan, C.D. Furberg, D.A. Johnson, K.W. Mahaffey, and E.M. Quigley ACCF/ACG/AHA 2008 Expert Consensus Document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Circulation 118 2008 1894 1909
13. J.D. Lewis, R. Schinnar, W.B. Bilker, X. Wang, and B.L. Strom Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research Pharmacoepidemiol Drug Saf 16 2007 393 401
14. A. Bourke, H. Dattani, and M. Robinson Feasibility study and methodology to create a quality-evaluated database of primary care data Inform Prim Care 12 2004 171 177
15. M. O'Neil, C. Payne, and J. Read Read Codes Version 3: a user led terminology Methods Inf Med 34 1995 187 192
16. B.T. Blak, M. Thompson, H. Dattani, and A. Bourke Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates Inform Prim Care 19 2011 251 255
17. E.L. De Schryver, J. van Gijn, L.J. Kappelle, P.J. Koudstaal, and A. Algra Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke J Neurol 252 2005 1316 1321
18. G. Singh, A. Mannalithara, A. Arora, A. Mithal, and G. Triadafilopoulos Concomitant proton pump inhibitor therapy improves adherence in low-dose aspirin users: a community-based study Eur Heart J 32 Abstract Suppl 2011 416
19. J. Bedson, T. Whitehurst, M. Lewis, and P. Croft Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease Br J Gen Pract 51 2001 1001 1003
20. N.C. Campbell, J. Thain, H.G. Deans, L.D. Ritchie, and J.M. Rawles Secondary prevention in coronary heart disease: baseline survey of provision in general practice BMJ 316 1998 1430 1434
21. S. Hopper, and M. Pierce Aspirin after myocardial infarction: the importance of over-the-counter use Fam Pract 15 Suppl 1 1998 S10 S13